JBS N.V. (JBS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, JBS N.V. (JBS) has a cash flow conversion efficiency ratio of 0.203x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($10.66 Billion) by net assets ($52.37 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
JBS N.V. - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how JBS N.V.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read JBS N.V. balance sheet liabilities for a breakdown of total debt and financial obligations.
JBS N.V. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of JBS N.V. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NAT.B.GR. SPONS.ADR/1
F:NAG
|
N/A |
|
The Siam Commercial Bank Public Company Limited
BK:SCB-R
|
0.028x |
|
YPF Sociedad Anónima
F:YPF
|
0.105x |
|
Lynas Rare EARTHS Ltd
AU:LYC
|
0.025x |
|
Universal Scientific Industrial Shanghai Co Ltd
SHG:601231
|
0.019x |
|
EDP RENOVAV. ADR /2 EO 5
F:EDW0
|
N/A |
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
0.057x |
|
Okta Inc
NASDAQ:OKTA
|
0.032x |
Annual Cash Flow Conversion Efficiency for JBS N.V. (2014–2025)
The table below shows the annual cash flow conversion efficiency of JBS N.V. from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of JBS N.V..
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $52.37 Billion | $15.49 Billion | 0.296x | -36.74% |
| 2024-12-31 | $50.37 Billion | $23.56 Billion | 0.468x | +91.15% |
| 2023-12-31 | $47.00 Billion | $11.50 Billion | 0.245x | -8.60% |
| 2022-12-31 | $49.81 Billion | $13.33 Billion | 0.268x | -40.43% |
| 2021-12-31 | $47.80 Billion | $21.48 Billion | 0.449x | -17.71% |
| 2020-12-31 | $43.54 Billion | $23.78 Billion | 0.546x | +28.85% |
| 2019-12-31 | $32.48 Billion | $13.77 Billion | 0.424x | +59.16% |
| 2018-12-31 | $27.95 Billion | $7.44 Billion | 0.266x | +33.78% |
| 2017-12-31 | $26.14 Billion | $5.20 Billion | 0.199x | +27.66% |
| 2016-12-31 | $23.52 Billion | $3.67 Billion | 0.156x | -37.45% |
| 2015-12-31 | $29.62 Billion | $7.38 Billion | 0.249x | -28.87% |
| 2014-12-31 | $25.64 Billion | $8.99 Billion | 0.350x | -- |
About JBS N.V.
JBS N.V., together with its subsidiaries, engages in the processing of animal proteins, encompassing activities related to beef, pork, lamb, and poultry worldwide. The company is involved in the production and marketing of prepared foods and other related products, as well as operations in leather, collagen, hygiene and beauty products, metal packaging, biodiesel, and other related businesses. It… Read more